Patients with chronic hepatitis C had elevated endocannabinoid levels in their blood, and these endocannabinoids suppressed immune responses while potentially promoting liver scarring.
Read this if you have hepatitis C and use cannabis, or are interested in how the endocannabinoid system affects liver disease.
Endocannabinoids suppressed antiviral immunity and promoted liver scarring
What the researchers found
Researchers measured endocannabinoid levels in hepatitis C patients and found both anandamide and 2-AG were elevated in plasma compared to healthy controls. However, liver tissue levels and degrading enzyme activity were unchanged.
In immune cells, endocannabinoids suppressed the production of key antiviral and inflammatory cytokines (IFN-gamma, TNF-alpha, IL-2). The suppressive effect of anandamide on IL-2 was stronger in cells from hepatitis C patients than healthy controls.
In liver cells, 2-AG induced expression of inflammatory markers (IL-6, IL-17A, IL-32, COX-2) and enhanced activation of hepatic stellate cells (which produce scar tissue). This suggests endocannabinoids may simultaneously weaken the immune response to the virus while promoting liver fibrosis.
Why it matters
Cannabis use has been associated with faster fibrosis progression in hepatitis C patients. This study provides a mechanism: elevated endocannabinoids (which cannabis use would further increase) suppress antiviral immunity and promote liver scarring.
The numbers in context
AEA and 2-AG elevated in HCV patient plasma; hepatic FAAH and MAGL activity unchanged; endocannabinoids suppressed IFN-gamma, TNF-alpha, IL-2; 2-AG induced IL-6, IL-17A, IL-32, COX-2 in hepatocytes
How the study worked
Translational study measuring endocannabinoid levels by mass spectrometry in plasma and liver tissue of HCV patients. Enzyme activity assays, gene expression analysis, and co-culture experiments with immune and liver cells.
What this study cannot tell us
Observational study with in vitro functional experiments. Sample sizes not specified in the abstract. In vitro cell responses may not fully reflect in vivo liver biology. The hepatitis C treatment landscape has changed dramatically.
How to read the evidence
Translational study combining clinical measurements with mechanistic cell experiments. Provides biological plausibility but not clinical proof.
When this study was published
Published in 2015. Hepatitis C is now curable with direct-acting antivirals, but the endocannabinoid-liver fibrosis connection remains relevant for other liver conditions.
The bigger picture
This study connects cannabis-related liver disease progression to specific endocannabinoid mechanisms, providing biological support for clinical recommendations against cannabis use in chronic hepatitis C patients.
Questions still open
- Does cannabis use directly worsen liver fibrosis in hepatitis C through these mechanisms? Would endocannabinoid system modulation improve hepatitis C treatment outcomes? Do these findings apply to other chronic liver diseases?
Common questions
Is cannabis bad for the liver?
Does this apply to people without hepatitis C?
Read the original research
Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.
International journal of molecular sciences, 16(4), 7057-76
Citation
Patsenker, Eleonora; Sachse, Philip; Chicca, Andrea; Gachet, María Salomé; Schneider, Vreni; Mattsson, Johan; Lanz, Christian; Worni, Mathias; de Gottardi, Andrea; Semmo, Mariam; Hampe, Jochen; Schafmayer, Clemens; Brenneisen, Rudolf; Gertsch, Jürg; Stickel, Felix; Semmo, Nasser. (2015). Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.. International journal of molecular sciences, 16(4), 7057-76. https://doi.org/10.3390/ijms16047057
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk